Insider Trading May 4, 2026 07:16 PM

TransUnion Executive Executes Stock Sale Amid Recent Price Volatility

Steven Chaouki, President of US Markets, liquidates $359,650 in common stock under a Rule 10b5-1 trading plan.

By Sofia Navarro TRU
TransUnion Executive Executes Stock Sale Amid Recent Price Volatility
TRU

Steven M. Chaouki, who serves as the President of US Markets for TransUnion (NYSE: TRU), has completed a sale of company stock. The transaction involved the disposal of 5,000 shares of common stock on May 1, 2026. The shares were sold at a price point of $71.93 per share, resulting in total proceeds of $359,650. This sale was conducted according to a pre-established Rule 10b5-1 trading plan. Following this divestment, Mr. Chaouki maintains a direct ownership stake of 84,711 shares in TransUnion common stock.

Key Points

  • TransUnion President Steven Chaouki sold 5,000 shares for $359,650 via a 10b5-1 plan.
  • First quarter 2026 results beat expectations with $1.25 billion in revenue and $1.18 EPS.
  • Analysts maintain positive ratings with price targets ranging from $85 to $95.

TransUnion's leadership has seen recent movement in equity holdings as the company navigates a period of share price fluctuation. Steven M. Chaouki, the President of US Markets at TransUnion (NYSE: TRU), executed a sale of 5,000 shares of the firm's common stock on May 1, 2026. The transaction was priced at $71.93 per share, totaling a value of $359,650. This divestment was carried out under the framework of a Rule 10b5-1 trading plan.


The timing of this sale occurs as TransUnion's stock has experienced a decline of 19% year-to-date. The stock is currently trading at $69.06, which is positioned near its 52-week low of $65.23. Despite the recent downward trend in share price, valuation metrics suggest a different perspective; for instance, a PEG ratio of 0.21 has been identified as indicating an attractive valuation relative to growth prospects, placing the company on lists for undervalued equities.


Key Market Observations

  • Executive Transaction: The sale by Steven Chaouki represents a notable movement by a high-level executive within the US Markets division.
  • Financial Outperformance: TransUnion recently reported first-quarter 2026 results that exceeded market expectations. The company posted earnings per share (EPS) of $1.18, which was higher than the anticipated $1.11. Additionally, revenue reached $1.25 billion, surpassing the forecasted $1.21 billion.
  • Analyst Optimism: Financial institutions have maintained positive outlooks. Needham has a Buy rating with a price target of $95.00, citing strength in mortgage and international sectors like Canada, the United Kingdom, and Africa. BMO Capital holds an Outperform rating with an $85.00 target, noting solid revenue and margin beats.

Risks and Market Uncertainties

  • Lending Environment Shifts: While the quarter was characterized by a constructive lending environment, BMO Capital noted signs of softening toward the end of the period. This potential shift impacts the broader credit and financial services sectors.
  • Equity Price Volatility: The 19% year-to-date decline and the proximity of current trading prices to the 52-week low reflect ongoing volatility in the equity markets for TransUnion.

The company's ability to deliver results across various international markets and its mortgage segment highlights a resilient operational framework, even as it faces fluctuating market conditions and shifting lending dynamics.

Risks

  • Potential softening in the lending environment noted by BMO Capital.
  • Significant year-to-date stock price decline of 19%.

More from Insider Trading

Bank of Hawaii Director Executes Common Stock Sale Amid Shifting Analyst Outlooks May 4, 2026 Slide Insurance Holdings CFO Executes Stock Sales Amid Recent Earnings Growth May 4, 2026 Slide Insurance CEO Executes $2.87 Million Stock Sale via Pre-Arranged Trading Plan May 4, 2026 Slide Insurance Executive Executes Stock Sales Under Pre-Arranged Plan May 4, 2026 Ligand Pharmaceuticals Executive Executes Rule 10b5-1 Stock Transactions Amid Strategic Portfolio Expansion May 4, 2026